These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22532293)

  • 1. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
    Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
    Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
    Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.
    Johnson DH; Taylor WR; Aboelsoud MM; Foote PH; Yab TC; Cao X; Smyrk TC; Loftus EV; Mahoney DW; Ahlquist DA; Kisiel JB
    Inflamm Bowel Dis; 2016 Jul; 22(7):1559-67. PubMed ID: 27104828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between methylation and colonic inflammation in inflammatory bowel disease.
    Lobatón T; Azuara D; Rodríguez-Moranta F; Loayza C; Sanjuan X; de Oca J; Fernández-Robles A; Guardiola J; Capellá G
    World J Gastroenterol; 2014 Aug; 20(30):10591-8. PubMed ID: 25132780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.
    Robles AI; Traverso G; Zhang M; Roberts NJ; Khan MA; Joseph C; Lauwers GY; Selaru FM; Popoli M; Pittman ME; Ke X; Hruban RH; Meltzer SJ; Kinzler KW; Vogelstein B; Harris CC; Papadopoulos N
    Gastroenterology; 2016 Apr; 150(4):931-43. PubMed ID: 26764183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.
    Papadia C; Louwagie J; Del Rio P; Grooteclaes M; Coruzzi A; Montana C; Novelli M; Bordi C; de' Angelis GL; Bassett P; Bigley J; Warren B; Atkin W; Forbes A
    Inflamm Bowel Dis; 2014 Feb; 20(2):271-7. PubMed ID: 24280874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.
    Carmona FJ; Azuara D; Berenguer-Llergo A; Fernández AF; Biondo S; de Oca J; Rodriguez-Moranta F; Salazar R; Villanueva A; Fraga MF; Guardiola J; Capellá G; Esteller M; Moreno V
    Cancer Prev Res (Phila); 2013 Jul; 6(7):656-65. PubMed ID: 23694962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease.
    Kisiel JB; Klepp P; Allawi HT; Taylor WR; Giakoumopoulos M; Sander T; Yab TC; Moum BA; Lidgard GP; Brackmann S; Mahoney DW; Roseth A; Ahlquist DA
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):914-921.e5. PubMed ID: 29775793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
    Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
    Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
    Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
    Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
    J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
    Kisiel JB; Yab TC; Nazer Hussain FT; Taylor WR; Garrity-Park MM; Sandborn WJ; Loftus EV; Wolff BG; Smyrk TC; Itzkowitz SH; Rubin DT; Zou H; Mahoney DW; Ahlquist DA
    Aliment Pharmacol Ther; 2013 Mar; 37(5):546-54. PubMed ID: 23347191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis.
    Kim TO; Park J; Kang MJ; Lee SH; Jee SR; Ryu DY; Yang K; Yi JM
    Int J Mol Med; 2013 May; 31(5):1255-61. PubMed ID: 23546389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.